与病人谈论:疫苗测试。

Q4 Medicine

Texas Medicine Pub Date : 2020-11-01

Sean Price

{"title":"与病人谈论:疫苗测试。","authors":"Sean Price","doi":"","DOIUrl":null,"url":null,"abstract":"The COVID-19 vaccines currently under production are expected to reach the public faster than any previous vaccine. But no matter how quickly a vaccine is produced, it still must pass a series of rigorous scientific tests before the U.S. Food and Drug Administration (FDA) will license it for public use.","PeriodicalId":39209,"journal":{"name":"Texas Medicine","volume":"116 11","pages":"23"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Talk to Patients About: Vaccine Testing.\",\"authors\":\"Sean Price\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The COVID-19 vaccines currently under production are expected to reach the public faster than any previous vaccine. But no matter how quickly a vaccine is produced, it still must pass a series of rigorous scientific tests before the U.S. Food and Drug Administration (FDA) will license it for public use.\",\"PeriodicalId\":39209,\"journal\":{\"name\":\"Texas Medicine\",\"volume\":\"116 11\",\"pages\":\"23\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Texas Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Texas Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

目前正在生产的COVID-19疫苗预计将比以往任何疫苗更快地到达公众手中。但是，不管一种疫苗的生产速度有多快，它仍然必须通过一系列严格的科学测试，然后才能获得美国食品和药物管理局(FDA)的许可，供公众使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Talk to Patients About: Vaccine Testing.

The COVID-19 vaccines currently under production are expected to reach the public faster than any previous vaccine. But no matter how quickly a vaccine is produced, it still must pass a series of rigorous scientific tests before the U.S. Food and Drug Administration (FDA) will license it for public use.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Texas Medicine Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： Texas Medicine is available to TMA members and presents timely information on public health, medicolegal issues, medical economics, science, medical education, and legislative affairs affecting Texas physicians and their patients.